News
-
-
-
COMMUNIQUÉ DE PRESSE
Immunic to Participate in Investor Conferences in November
-
-
-
COMMUNIQUÉ DE PRESSE
Immunic to Host Virtual Progressive Multiple Sclerosis R&D Day on November 5, 2026
-
-
-
COMMUNIQUÉ DE PRESSE
Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 – the 10th Joint ACTRIMS-ECTRIMS Meeting
Immunic presents new clinical, biomarker, and preclinical data for Vidofludimus Calcium in four poster presentations at MSToronto2026. Significant findings supporting treatment effects and disease progression in multiple sclerosis patients -